Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 687


A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Jul 25. pii: S1353-8020(18)30327-4. doi: 10.1016/j.parkreldis.2018.07.016. [Epub ahead of print]


Exoskeleton-Robot Assisted Therapy in Stroke Patients: A Lesion Mapping Study.

Cerasa A, Pignolo L, Gramigna V, Serra S, Olivadese G, Rocca F, Perrotta P, Dolce G, Quattrone A, Tonin P.

Front Neuroinform. 2018 Jul 17;12:44. doi: 10.3389/fninf.2018.00044. eCollection 2018.


Analysis of the TMEM230 gene in patients with multiple system atrophy.

Procopio R, Gagliardi M, Brighina L, Nicoletti G, Morelli M, Piatti M, Annesi G, Quattrone A.

J Neurol Sci. 2018 Sep 15;392:128-129. doi: 10.1016/j.jns.2018.07.019. Epub 2018 Jul 23. No abstract available.


Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.

Barone S, Caligiuri ME, Valentino P, Cherubini A, Chiriaco C, Granata A, Filippelli E, Tallarico T, Nisticò R, Quattrone A.

J Neurol. 2018 Jul 26. doi: 10.1007/s00415-018-8980-y. [Epub ahead of print]


HuD Is a Neural Translation Enhancer Acting on mTORC1-Responsive Genes and Counteracted by the Y3 Small Non-coding RNA.

Tebaldi T, Zuccotti P, Peroni D, Köhn M, Gasperini L, Potrich V, Bonazza V, Dudnakova T, Rossi A, Sanguinetti G, Conti L, Macchi P, D'Agostino V, Viero G, Tollervey D, Hüttelmaier S, Quattrone A.

Mol Cell. 2018 Jul 19;71(2):256-270.e10. doi: 10.1016/j.molcel.2018.06.032.


Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data.

Saccà V, Sarica A, Novellino F, Barone S, Tallarico T, Filippelli E, Granata A, Chiriaco C, Bruno Bossio R, Valentino P, Quattrone A.

Brain Imaging Behav. 2018 Jul 11. doi: 10.1007/s11682-018-9926-9. [Epub ahead of print]


DNAJC13 mutation screening in patients with Parkinson's disease from South Italy.

Gagliardi M, Annesi G, Procopio R, Morelli M, Iannello G, Bonapace G, Mancini M, Nicoletti G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jun 4. pii: S1353-8020(18)30263-3. doi: 10.1016/j.parkreldis.2018.06.004. [Epub ahead of print]


Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Arabia G, Lupo A, Manfredini LI, Vescio B, Nisticò R, Barbagallo G, Salsone M, Morelli M, Novellino F, Nicoletti G, Quattrone A, Cascini GL, Louis ED, Quattrone A.

Parkinsonism Relat Disord. 2018 Jun 5. pii: S1353-8020(18)30264-5. doi: 10.1016/j.parkreldis.2018.06.005. [Epub ahead of print]


SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.

Liang Y, Tebaldi T, Rejeski K, Joshi P, Stefani G, Taylor A, Song Y, Vasic R, Maziarz J, Balasubramanian K, Ardasheva A, Ding A, Quattrone A, Halene S.

Leukemia. 2018 Jun 1. doi: 10.1038/s41375-018-0152-7. [Epub ahead of print]


Mutational analysis of TARDBP gene in patients affected by Parkinson's disease from Calabria.

Gagliardi M, Arabia G, Nisticò R, Iannello G, Procopio R, Manfredini L, Annesi G, Quattrone A.

J Neurol Sci. 2018 Jul 15;390:209-211. doi: 10.1016/j.jns.2018.04.043. Epub 2018 May 1.


Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.

Aveic S, Pantile M, Polo P, Sidarovich V, De Mariano M, Quattrone A, Longo L, Tonini GP.

Cancer Cell Int. 2018 Apr 24;18:63. doi: 10.1186/s12935-018-0557-4. eCollection 2018.


Midbrain meningioma causing subacute parkinsonism.

Labate A, Nisticò R, Cherubini A, Quattrone A.

Neurol Clin Pract. 2018 Apr;8(2):166-168. doi: 10.1212/CPJ.0000000000000439. No abstract available.


A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.

Sidarovich V, De Mariano M, Aveic S, Pancher M, Adami V, Gatto P, Pizzini S, Pasini L, Croce M, Parodi F, Cimmino F, Avitabile M, Emionite L, Cilli M, Ferrini S, Pagano A, Capasso M, Quattrone A, Tonini GP, Longo L.

Mol Cancer Ther. 2018 Jul;17(7):1405-1415. doi: 10.1158/1535-7163.MCT-17-0841. Epub 2018 Apr 25.


Positioning Europe for the EPITRANSCRIPTOMICS challenge.

Jantsch MF, Quattrone A, O'Connell M, Helm M, Frye M, Macias-Gonzales M, Ohman M, Ameres S, Willems L, Fuks F, Oulas A, Vanacova S, Nielsen H, Bousquet-Antonelli C, Motorin Y, Roignant JY, Balatsos N, Dinnyes A, Baranov P, Kelly V, Lamm A, Rechavi G, Pelizzola M, Liepins J, Holodnuka Kholodnyuk I, Zammit V, Ayers D, Drablos F, Dahl JA, Bujnicki J, Jeronimo C, Almeida R, Neagu M, Costache M, Bankovic J, Banovic B, Kyselovic J, Valor LM, Selbert S, Pir P, Demircan T, Cowling V, Schäfer M, Rossmanith W, Lafontaine D, David A, Carre C, Lyko F, Schaffrath R, Schwartz S, Verdel A, Klungland A, Purta E, Timotijevic G, Cardona F, Davalos A, Ballana E, O Carroll D, Ule J, Fray R.

RNA Biol. 2018 May 9:1-3. doi: 10.1080/15476286.2018.1460996. [Epub ahead of print]


Hydrogen peroxide is a neuronal alarmin that triggers specific RNAs, local translation of Annexin A2, and cytoskeletal remodeling in Schwann cells.

Negro S, Stazi M, Marchioretto M, Tebaldi T, Rodella U, Duregotti E, Gerke V, Quattrone A, Montecucco C, Rigoni M, Viero G.

RNA. 2018 Jul;24(7):915-925. doi: 10.1261/rna.064816.117. Epub 2018 Apr 11.


Antidepressant-like actions by silencing of neuronal ELAV-like RNA-binding proteins HuB and HuC in a model of depression in male mice.

Sanna MD, Quattrone A, Galeotti N.

Neuropharmacology. 2018 Jun;135:444-454. doi: 10.1016/j.neuropharm.2018.04.001. Epub 2018 Apr 5.


Editorial on special issue: Machine learning on MCI.

Sarica A, Cerasa A, Quattrone A, Calhoun V.

J Neurosci Methods. 2018 May 15;302:1-2. doi: 10.1016/j.jneumeth.2018.03.011. Epub 2018 Mar 23. No abstract available.


The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.

Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasà M, Quattrone A, Bianco MG, Morelli M, Augimeri A, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jul;52:17-23. doi: 10.1016/j.parkreldis.2018.03.012. Epub 2018 Mar 14.


Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.

Thongon N, Zucal C, D'Agostino VG, Tebaldi T, Ravera S, Zamporlini F, Piacente F, Moschoi R, Raffaelli N, Quattrone A, Nencioni A, Peyron JF, Provenzani A.

Cancer Metab. 2018 Mar 8;6:1. doi: 10.1186/s40170-018-0174-7. eCollection 2018.


Cardiac parasympathetic index identifies subjects with adult obstructive sleep apnea: A simultaneous polysomnographic-heart rate variability study.

Salsone M, Vescio B, Quattrone A, Roccia F, Sturniolo M, Bono F, Aguglia U, Gambardella A, Quattrone A.

PLoS One. 2018 Mar 8;13(3):e0193879. doi: 10.1371/journal.pone.0193879. eCollection 2018.


Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.

Manna I, Iaccino E, Dattilo V, Barone S, Vecchio E, Mimmi S, Filippelli E, Demonte G, Polidoro S, Granata A, Scannapieco S, Quinto I, Valentino P, Quattrone A.

FASEB J. 2018 Aug;32(8):4241-4246. doi: 10.1096/fj.201701533R. Epub 2018 Mar 5.


Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease.

Piro A, Tagarelli A, Nicoletti G, Scannapieco S, Polidoro S, Valentino P, Quattrone A.

Int Ophthalmol. 2018 Feb 1. doi: 10.1007/s10792-018-0838-x. [Epub ahead of print]


Physiological Aging Influence on Brain Hemodynamic Activity during Task-Switching: A fNIRS Study.

Vasta R, Cutini S, Cerasa A, Gramigna V, Olivadese G, Arabia G, Quattrone A.

Front Aging Neurosci. 2018 Jan 8;9:433. doi: 10.3389/fnagi.2017.00433. eCollection 2017.


Value of clinical features to differentiate refractory epilepsy from mimics: a prospective longitudinal cohort study.

Labate A, Mumoli L, Curcio A, Tripepi G, D'Arrigo G, Ferlazzo E, Aguglia U, Indolfi C, Quattrone A, Gambardella A.

Eur J Neurol. 2018 May;25(5):711-717. doi: 10.1111/ene.13579. Epub 2018 Mar 1.


Relationship between Hippocampal Subfields and Category Cued Recall in AD and PDD: A Multimodal MRI Study.

Novellino F, Vasta R, Sarica A, Chiriaco C, Salsone M, Morelli M, Arabia G, Saccà V, Nicoletti G, Quattrone A.

Neuroscience. 2018 Feb 10;371:506-517. doi: 10.1016/j.neuroscience.2017.12.028. Epub 2017 Dec 29.


Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment.

Barone S, Scannapieco S, Torti C, Filippelli E, Pisani V, Granata A, Console D, Demonte G, Tallarico T, Polidoro S, Quattrone A, Valentino P.

Mult Scler Relat Disord. 2018 Feb;20:6-8. doi: 10.1016/j.msard.2017.12.009. Epub 2017 Dec 18.


Corrigendum to "A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy" [J. Neurol. Sci. 381C (2017) 209-212].

Iannello G, Graziano C, Cenacchi G, Cordelli DM, Zuntini R, Papa V, Magistà AM, Gagliardi M, Procopio R, Quattrone A, Annesi G.

J Neurol Sci. 2018 Feb 15;385:238. doi: 10.1016/j.jns.2017.12.002. Epub 2017 Dec 15. No abstract available.


A new CHCHD2 mutation identified in a southern italy patient with multiple system atrophy.

Nicoletti G, Gagliardi M, Procopio R, Iannello G, Morelli M, Annesi G, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:91-93. doi: 10.1016/j.parkreldis.2017.12.005. Epub 2017 Dec 7. No abstract available.


Color vision as a biological marker able to differentiate two phenotypically similar neurological diseases.

Piro A, Tagarelli A, Nicoletti G, Chiriaco C, Novellino F, Quattrone A.

Neurol Sci. 2018 May;39(5):951-952. doi: 10.1007/s10072-017-3219-8. Epub 2017 Dec 14. No abstract available.


Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.

Barbagallo G, Arabia G, Novellino F, Nisticò R, Salsone M, Morelli M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:57-63. doi: 10.1016/j.parkreldis.2017.11.345. Epub 2017 Nov 28.


TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy.

Aveic S, Corallo D, Porcù E, Pantile M, Boso D, Zanon C, Viola G, Sidarovich V, Mariotto E, Quattrone A, Basso G, Tonini GP.

Eur J Pharmacol. 2018 Jan 5;818:435-448. doi: 10.1016/j.ejphar.2017.11.016. Epub 2017 Nov 14.


The challenge of mapping the human connectome based on diffusion tractography.

Maier-Hein KH, Neher PF, Houde JC, Côté MA, Garyfallidis E, Zhong J, Chamberland M, Yeh FC, Lin YC, Ji Q, Reddick WE, Glass JO, Chen DQ, Feng Y, Gao C, Wu Y, Ma J, Renjie H, Li Q, Westin CF, Deslauriers-Gauthier S, González JOO, Paquette M, St-Jean S, Girard G, Rheault F, Sidhu J, Tax CMW, Guo F, Mesri HY, Dávid S, Froeling M, Heemskerk AM, Leemans A, Boré A, Pinsard B, Bedetti C, Desrosiers M, Brambati S, Doyon J, Sarica A, Vasta R, Cerasa A, Quattrone A, Yeatman J, Khan AR, Hodges W, Alexander S, Romascano D, Barakovic M, Auría A, Esteban O, Lemkaddem A, Thiran JP, Cetingul HE, Odry BL, Mailhe B, Nadar MS, Pizzagalli F, Prasad G, Villalon-Reina JE, Galvis J, Thompson PM, Requejo FS, Laguna PL, Lacerda LM, Barrett R, Dell'Acqua F, Catani M, Petit L, Caruyer E, Daducci A, Dyrby TB, Holland-Letz T, Hilgetag CC, Stieltjes B, Descoteaux M.

Nat Commun. 2017 Nov 7;8(1):1349. doi: 10.1038/s41467-017-01285-x.


Personality biomarkers of pathological gambling: A machine learning study.

Cerasa A, Lofaro D, Cavedini P, Martino I, Bruni A, Sarica A, Mauro D, Merante G, Rossomanno I, Rizzuto M, Palmacci A, Aquino B, De Fazio P, Perna GR, Vanni E, Olivadese G, Conforti D, Arabia G, Quattrone A.

J Neurosci Methods. 2018 Jan 15;294:7-14. doi: 10.1016/j.jneumeth.2017.10.023. Epub 2017 Nov 1.


In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology.

Bernabò P, Tebaldi T, Groen EJN, Lane FM, Perenthaler E, Mattedi F, Newbery HJ, Zhou H, Zuccotti P, Potrich V, Shorrock HK, Muntoni F, Quattrone A, Gillingwater TH, Viero G.

Cell Rep. 2017 Oct 24;21(4):953-965. doi: 10.1016/j.celrep.2017.10.010.


Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer's Disease: A Systematic Review.

Sarica A, Cerasa A, Quattrone A.

Front Aging Neurosci. 2017 Oct 6;9:329. doi: 10.3389/fnagi.2017.00329. eCollection 2017. Review.


A new PLA2G6 mutation in a family with infantile neuroaxonal dystrophy.

Iannello G, Graziano C, Cenacchi G, Cordelli DM, Zuntini R, Papa V, Magistà AM, Gagliardi M, Procopio R, Quattrone A, Annesi G.

J Neurol Sci. 2017 Oct 15;381:209-212. doi: 10.1016/j.jns.2017.08.3260. Epub 2017 Sep 1. Erratum in: J Neurol Sci. 2017 Dec 15;:.


Neuropsychological heterogeneity in patients with primary familial brain calcification due to a novel mutation in SLC20A2.

Chiriaco C, Novellino F, Salsone M, Gagliardi M, Morelli M, Quattrone A.

Neurol Sci. 2018 Feb;39(2):379-380. doi: 10.1007/s10072-017-3125-0. Epub 2017 Sep 21. No abstract available.


Regulation of HuR structure and function by dihydrotanshinone-I.

Lal P, Cerofolini L, D'Agostino VG, Zucal C, Fuccio C, Bonomo I, Dassi E, Giuntini S, Di Maio D, Vishwakarma V, Preet R, Williams SN, Fairlamb MS, Munk R, Lehrmann E, Abdelmohsen K, Elezgarai SR, Luchinat C, Novellino E, Quattrone A, Biasini E, Manzoni L, Gorospe M, Dixon DA, Seneci P, Marinelli L, Fragai M, Provenzani A.

Nucleic Acids Res. 2017 Sep 19;45(16):9514-9527. doi: 10.1093/nar/gkx623.


Ictal 18F-FDG PET/MRI in a Patient With Cortical Heterotopia and Focal Epilepsy.

Calabria FF, Cascini GL, Gambardella A, Labate A, Cherubini A, Gullà D, Tafuri B, Sabatini U, Vescio V, Quattrone A.

Clin Nucl Med. 2017 Oct;42(10):768-769. doi: 10.1097/RLU.0000000000001797.


Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals.

Mumoli L, Tripepi G, Aguglia U, Augimeri A, Baggetta R, Bisulli F, Bruni A, Cavalli SM, D'Aniello A, Daniele O, Di Bonaventura C, Di Gennaro G, Fattouch J, Ferlazzo E, Ferrari A, Giallonardo A, Gasparini S, Nigro S, Romigi A, Sofia V, Tinuper P, Vaccaro MG, Zummo L, Quattrone A, Gambardella A, Labate A.

Behav Sci (Basel). 2017 Aug 7;7(3). pii: E50. doi: 10.3390/bs7030050.


Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study.

Barbagallo G, Arabia G, Morelli M, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2017 Oct;43:78-84. doi: 10.1016/j.parkreldis.2017.07.028. Epub 2017 Jul 28.


Head trauma and Parkinson's disease: results from an Italian case-control study.

Nicoletti A, Vasta R, Mostile G, Nicoletti G, Arabia G, Iliceto G, Lamberti P, Marconi R, Morgante L, Barone P, Quattrone A, Zappia M.

Neurol Sci. 2017 Oct;38(10):1835-1839. doi: 10.1007/s10072-017-3076-5. Epub 2017 Jul 26.


Structural connectivity differences in essential tremor with and without resting tremor.

Caligiuri ME, Arabia G, Barbagallo G, Lupo A, Morelli M, Nisticò R, Novellino F, Quattrone A, Salsone M, Vescio B, Cherubini A, Quattrone A.

J Neurol. 2017 Sep;264(9):1865-1874. doi: 10.1007/s00415-017-8553-5. Epub 2017 Jul 20.


Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Barbagallo G, Caligiuri ME, Arabia G, Cherubini A, Lupo A, Nisticò R, Salsone M, Novellino F, Morelli M, Cascini GL, Galea D, Quattrone A.

Hum Brain Mapp. 2017 Sep;38(9):4716-4729. doi: 10.1002/hbm.23697. Epub 2017 Jun 20.


Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.

Sanna MD, Quattrone A, Galeotti N.

Neuropharmacology. 2017 Sep 1;123:116-125. doi: 10.1016/j.neuropharm.2017.06.005. Epub 2017 Jun 12.


MRI measures of brainstem in Parkinsonian syndromes: Where we stand and where we need to go.

Quattrone A, Nigro S.

Mov Disord. 2017 Aug;32(8):1261. doi: 10.1002/mds.27056. Epub 2017 Jun 7. No abstract available.


Camptocormia as presenting in lower motor neuron disease with TARDBP mutation: case report.

Filippelli E, Valentino P, Annesi G, Nisticò R, Quattrone A.

Neurol Sci. 2017 Oct;38(10):1885-1887. doi: 10.1007/s10072-017-3005-7. Epub 2017 Jun 1. No abstract available.


Macrophage infiltration and genetic landscape of undifferentiated uterine sarcomas.

Przybyl J, Kowalewska M, Quattrone A, Dewaele B, Vanspauwen V, Varma S, Vennam S, Newman AM, Swierniak M, Bakuła-Zalewska E, Siedlecki JA, Bidzinski M, Cools J, van de Rijn M, Debiec-Rychter M.

JCI Insight. 2017 Jun 2;2(11). pii: 94033. doi: 10.1172/jci.insight.94033. [Epub ahead of print]


Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?

Nigro S, Morelli M, Arabia G, Nisticò R, Novellino F, Salsone M, Rocca F, Quattrone A.

Parkinsonism Relat Disord. 2017 Aug;41:31-36. doi: 10.1016/j.parkreldis.2017.05.002. Epub 2017 May 3.


Supplemental Content

Loading ...
Support Center